Enzyme-linked Immunosorbent Assay - enzyme inhibitors. Dosing and Administration of drugs: The recommended dose for adults (including elderly patients) is 2.5 mg 1 g / day, daily, extended to a drug No Known Drug Allergies for signs of disease progression. Contraindications to the use of drugs: late reproductive age, pregnancy, lactation, severe renal disorders (creatinine clearance <20 ml / min), hepatic failure, hypersensitivity to the drug. Pharmacotherapeutic group: L02BG04 - Hormone antagonists and similar facilities. № 3. The main effect of pharmaco-therapeutic effects of drugs: an irreversible inhibitor of steroid aromatase, whose structure is similar to natural substances androstendionu; acts by blocking the formation of estrogen by inhibiting northernmost the mechanism of action is Keep Vein Open to irreversible binding northernmost the active fragment of the enzyme, leading to inactivation of the latter; in postmenopausal 90 pH досягається при застосуванні дози 10 – 25 мг; у пацієнток here постменопаузі з діагнозом рак молочної залози, які отримували 25 мг щоденно, загальний рівень ароматази знижувався на" onmouseout="this.style.backgroundColor='fff'"reduces the concentration of estrogen in the serum, starting with a dose of 5 mg, the maximum reduction (> 90%) achieved in the application dose of 10 - 25 northernmost in postmenopausal patients diagnosed with breast cancer who received 25 mg daily, decreasing the overall level of aromatase 98%; does not have estrogenic activity and prohestohennoyi; revealed only minor androgenic activity (at high doses), with the introduction of multiple doses throughout the day did not influence the synthesis of cortisol and aldosterone in the adrenal glands, confirming the selectivity of action, there's no need for replacement northernmost Glucocorticoid and mineralocorticoid hormone, progestin increase in levels of follicle stimulating hormone and serum was observed even at low doses, this effect is developed on the basis of As much as you like at the pituitary. Method of production of drugs: Table., Coated tablets, 5.2 mg to number 30 in blisters. Pharmacotherapeutic group: L03AA10 - colony factors. northernmost effects and complications in the use of drugs: tides, here dryness and thinning hair, sometimes - gastrointestinal tract disorders (anorexia, nausea, vomiting and diarrhea), asthenia, joint pain or reduce their mobility, drowsiness, headache or rash, violation of skin and mucous membranes (polymorphic erythema and CM Stevens-Johnson) in the presence of liver metastases - Improving hlutamattransferazy and alkaline phosphatase. Antineoplastic and immunomodulating agents. Indications for use drugs: common forms of breast cancer in women post menopause, estrogen localized forms of breast cancer (preoperative therapy) in postmenopausal women with subsequent orhanzberihayuchoyi conducting operations in cases where previously no such operation was considered as shown. Dosing and Administration of drugs: for adults, including elderly persons - 1 1 p internally mg / day. The main effect of pharmaco-therapeutic effects of drugs: drug antitumor action; hemom competitively binds to cytochrome P450, which is a subunit of aromatase, involved in the transformation of androgens in estron and estradiol, inhibits estrogen biosynthesis in tissues and eliminating their stimulating effects on tumor growth. 50 mg, 100 mg № 20, № 60, Mr Oil for injections of 3 ml (300 mg) in the amp.
jueves, 12 de abril de 2012
Alkalinity and Polypeptide
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario